Investor Presentaiton

CSL Behring Plasma Highlights. Underlying fundamentals of plasma collection remain strong • 10% reduction in CPL • • Expanding geographic footprint of plasma collection network RIKA Currently >30 centres converted Roll out plan over next 18 months Individualised Nomogram filed with the FDA Gross margin recovery underway 1. US only and average over the periods. 6 Driven by Our Promise Benefits of RIKA Plasma Donation System • • Fewer donor deferrals; reduced donation time by ~30% Individualised Nomogram will improve average donation yield by ~10% Reduced biohazard disposable waste by 10-15% Improved productivity CSL

View entire presentation